针刺五脏俞加膈俞治疗心脾两虚型失眠临床观察

Clinical Observation on Acupuncture Therapy in Treating Insomnia with Deficiency of Heart and Spleen by Acupuncture Back-shu points of five zang and Geshu (BL17)

目的观察针刺五脏俞加膈俞对心脾两虚型失眠的临床疗效。方法本研究采用随机、对照的研究方法,将符合纳入标准的100例心脾两虚型失眠患者随机分为治疗组(50例)和对照组(50例),治疗组采用针刺五脏俞加膈俞,对照组口服艾司唑仑。2组均治疗4周后观察临床疗效。结果治疗后观察组PSQI评分(8.58±2.98)低于对照组(9.68±2.20),差异具有统计学意义(P<0.05)。治疗后观察组中医证候评分(16.48±4.82)低于对照组(19.64±4.25),差异具有统计学意义(P<0.05)。失眠疗效观察组总有效率(86.0%)高于对照组(68.0%),差异具有统计学意义(P<0.05)。心脾两虚证疗效观察组总有效率(90.0%)高于对照组(64.0%),差异具有统计学意义(P<0.05)。结论针刺五脏俞加膈俞治疗心脾两虚型失眠具有良好的临床效果。

Objective To observe the effect of the acupuncture therapy in treating insomnia with deficiency of heart and spleen by acupuncture back-shu points of five zang and Geshu(BL17). Method A randomized, controlled study was used in this study. 100 cases of insomnia patients with deficiency of heart and spleen were randomly divided into treatment group(50 cases) and control group(50 cases). The treatment group received acupuncture back-shu points of five zang and Geshu(BL17) for 4 weeks, and the control group received Estazolam by oral for 4 weeks. After 4 weeks of treatment, clinical efficacy was observed in both groups. Result After treatment, the total PSQI score was(8.58±2.98) in the treatment group, which was significantly lower than(9.68±2.20) in the control group, and the difference was statistically significant(P<0.05). The score of TCM syndromes was(16.48±4.82) in the treatment group, which was significantly lower than(19.64±4.25) in the control group, and the difference was statistically significant(P<0.05). The insomnia effective rate was 86.0% in the treatment group and 68.0% in the control group. The difference was statistically significant(P<0.05). The deficiency of heart and spleen effective rate was 90.0% in the treatment group and 64.0% in the control group. The difference was statistically significant(P<0.05). Conclusion The acupuncture therapy for treating insomnia with deficiency of heart and spleen by acupuncture back-shu points of five zang and Geshu(BL17) has good clinical effect.